Clinical Trials · NCT07702461

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

RecruitingN/ATirzepatide (Investigational)Semaglutide (Investigational)Liraglutide (Investigational)Dulaglutide (Investigational)Exenatide (Investigational)
Phase
N/A
Recruitment status
Recruiting
Sponsor
Ohio State University
Enrollment
300
Start date
Jun 2026
Locations
1 site, United States
Primary endpoint
Change in Resistance Training Status Before Versus Since GLP-1 Receptor Agonist Initiation
View Tirzepatide compound reference